Taurine: Evidence-Based Benefits, Dosage & Safety (UK Guide)

Taurine is a sulphur-containing amino acid found in high concentrations in the brain, heart, skeletal muscle and retina. Unlike most amino acids, it isn't used to build proteins — it acts more like a regulator, involved in cell volume, membrane stability and bile acid conjugation. The human body synthesises it in small amounts, and dietary intake (mainly from meat and fish) tops that up. Plasma taurine concentrations in healthy adults typically sit around 40–100 µmol/L, and supplemental doses between 1,000mg and 6,000mg per day have been used in clinical research.

What is Taurine?

Taurine (2-aminoethanesulphonic acid) is one of the most abundant free amino acids in human tissue. It's often called a "conditionally essential" amino acid — your body can make it from cysteine and methionine, but not always in sufficient quantities under physiological stress, illness, or during periods of rapid growth. Dietary sources include meat, poultry, seafood and dairy; strict vegans tend to have lower plasma taurine levels because plant foods contain almost none. The supplement form used in KōJō Daily Formula is crystalline powder — the same form used in the majority of clinical trials.

Mechanistically, taurine doesn't slot neatly into one system. Oja et al. (2008) describe its pharmacology as spanning osmoregulation (helping cells manage water balance), modulation of inhibitory neurotransmission via GABA-A and glycine receptors, antioxidant activity through scavenging of hypochlorous acid, and calcium signalling in cardiac and skeletal muscle. That breadth is part of why it appears in research across so many different health areas — and also part of why definitive conclusions are harder to draw than the energy drink marketing would have you believe.

In the body, taurine is not stored in proteins — it exists as a free amino acid in the intracellular space. The brain, retina and heart contain the highest concentrations. Chesney (1986) noted that taurine accounts for more than 50% of the total free amino acid pool in cardiac tissue, which gives some context for why cardiovascular researchers have taken a particular interest in it. It's also a precursor to bile salts (taurocholic acid), meaning it plays a quiet but real role in fat digestion.

Clinical Evidence

The honest starting point is that taurine's evidence base in humans is promising but genuinely patchy. Most of the mechanistic work is animal-derived, and the human RCTs that do exist tend to be small, short, and not always well-controlled. That said, there are some areas where the data is more convincing than others.

Cardiovascular function is probably the most studied area. Several small RCTs have looked at taurine's effect on blood pressure and arterial function. A meta-analysis of seven RCTs (n = 301 participants) found that taurine supplementation at doses ranging from 1,000mg to 6,000mg per day was associated with modest reductions in systolic and diastolic blood pressure, though the authors noted significant heterogeneity between trials and cautioned against overinterpretation. Oja et al. (2008) situate these findings within taurine's known role in calcium handling and vascular smooth muscle — a plausible mechanism, even if the human data remains limited in scale.

Exercise physiology is another area researchers have explored. Taurine is a constituent of many energy drink formulations, and Jagim et al. (2023) — the International Society of Sports Nutrition's position stand on energy drinks — acknowledge that taurine may play a role in reducing exercise-induced oxidative stress, though they are careful to note that isolating taurine's contribution from caffeine and other co-ingredients in energy drink studies is methodologically difficult. Standalone taurine RCTs in exercise contexts are fewer, and effect sizes where reported tend to be modest.

Neurological and retinal function represent the areas most supported by basic science. Chesney (1986) documented that taurine deficiency in cats causes irreversible retinal degeneration — a finding that has informed clinical guidance on taurine supplementation in certain paediatric populations receiving parenteral nutrition. In humans, severe deficiency states (rare, but documented in long-term parenteral nutrition without taurine supplementation) have been associated with retinal dysfunction. Whether supplementation in otherwise healthy adults with adequate dietary intake produces measurable retinal or neurological benefit is a different question, and the evidence is thin.

Some research has examined taurine in the context of metabolic health. Wu et al. (2022) explored relationships between gut microbiome composition, bile acid metabolism (in which taurine participates as a bile acid conjugate) and thermogenesis in animal models — interesting mechanistically, but not yet translatable to direct supplementation claims in humans. The gut microbiome angle is one I find genuinely interesting, though it would be dishonest to dress it up as settled science at this stage.

One further area worth noting is taurine's potential role in osmoprotection under conditions of physiological stress. Oja et al. (2008) describe how taurine may help stabilise cell membranes under oxidative and osmotic stress — a mechanism that could theoretically matter during intense physical exertion or periods of poor dietary intake. Jagim et al. (2023) acknowledge this line of reasoning but stop well short of endorsing taurine as a standalone ergogenic aid, which I think is the right call given the current evidence. To put it plainly: the biology is interesting, the human RCT data is limited, and anyone telling you otherwise is getting ahead of the science.

Dosage: What Research Supports

Clinical trials have used a wide range of doses — from as low as 500mg per day up to 6,000mg per day — with the most commonly studied range sitting between 1,000mg and 3,000mg per day. The European Food Safety Authority (EFSA) assessed taurine in 2009 in the context of energy drinks and concluded that intakes up to 6,000mg per day were unlikely to pose a safety concern in healthy adults. There are no formal NHS or EFSA dietary reference values for taurine as a nutrient, since it's not classified as an essential vitamin or mineral — but the safety review does provide a useful upper reference point.

Most of the cardiovascular RCTs showing possible effects used doses in the 1,500mg–3,000mg range, administered over periods of four to twelve weeks. The neurological literature, particularly in deficiency contexts, suggests that even lower doses may be sufficient to restore plasma levels in people who are genuinely depleted. For healthy adults eating a varied omnivorous diet, baseline plasma taurine is typically adequate, so the question of what supplementation adds at the margin is still being worked out in the research.

KōJō Daily Formula provides 2,000mg of taurine as crystalline powder per serving. That dose sits comfortably within the range used in clinical research and well below EFSA's assessed safe upper level of 6,000mg per day. It's a dose I'm comfortable standing behind — not because I think it's magic at that number, but because it's where the most credible human data clusters.

How KōJō Uses Taurine

Taurine is the third of 42 active ingredients in KōJō Daily Formula, and I chose crystalline powder specifically because it's the form used in the clinical literature — not a proprietary derivative, not a novel delivery system, just the same compound researchers have actually studied. Crystalline taurine has excellent aqueous solubility and high bioavailability, which matters when you're combining it with other water-soluble ingredients in a single daily serving.

At 2,000mg per serving, it sits alongside other ingredients that operate across cardiovascular, neurological and metabolic pathways. I'm not going to claim taurine "works synergistically" with everything else in the formula — that kind of language tends to obscure more than it reveals. What I can say is that the dose is deliberate, the form is evidence-appropriate, and it's one of the ingredients I feel most confident about from a safety standpoint given the depth of the existing pharmacological review.

Safety and Considerations

Taurine has a well-established safety profile at the doses used in research. In the EFSA review of energy drink ingredients, taurine at up to 6,000mg per day was not associated with adverse effects in healthy adults. At 2,000mg — the dose in KōJō Daily Formula — reported side effects in clinical trials have been minimal and generally limited to mild gastrointestinal discomfort in a small number of participants. There is no credible evidence of toxicity at supplemental doses in the range used here. Oja et al. (2008) note that taurine's wide distribution across tissues and its rapid renal clearance at higher plasma concentrations both contribute to its tolerability.

That said, the usual caveats apply. People with chronic kidney disease should be cautious, since taurine is cleared renally and impaired excretion could theoretically lead to accumulation. Taurine may also interact with lithium — there is some early evidence suggesting it could affect lithium excretion, though this is not well characterised in humans. Consult a healthcare professional before starting taurine if you are pregnant, breastfeeding, taking medication, or have an underlying condition. KōJō Daily Formula provides 2,000mg of crystalline powder per serving — stay within the single-serving guidance.

Frequently asked questions

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.